HARP - Harpoon Therapeutics Inc
Close
23.01
0.020 0.087%
Share volume: 0
Last Updated: Fri 08 Mar 2024 10:00:00 PM CET
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$22.99
0.02
0.09%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-12 | 2022-08-10 | 2022-11-14 | 2023-03-27 | 2023-05-11 | 2023-08-09 | 2023-11-09 | |
Total revenue | 5.906 M | 8.303 M | 13.617 M | 4.089 M | 8.583 M | 20.221 M | 4.448 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 5.906 M | 8.303 M | 13.617 M | 4.089 M | 8.583 M | 20.221 M | 4.448 M | |
40.59% | 64.00% | -69.97% | 109.90% | 135.59% | -78.00% | |||
Operating expenses | 26.219 M | 25.714 M | 25.506 M | 22.801 M | 19.348 M | 15.999 M | 16.587 M | |
Selling general and admin | 5.401 M | 5.063 M | 4.529 M | 3.854 M | 4.185 M | 3.803 M | 4.262 M | |
Research and development | 20.818 M | 20.651 M | 20.977 M | 18.947 M | 15.163 M | 12.196 M | 12.325 M | |
Total expenses | 26.219 M | 25.714 M | 25.506 M | 22.801 M | 19.348 M | 15.999 M | 16.587 M | |
-1.93% | -0.81% | -10.61% | -15.14% | -17.31% | 3.68% | |||
Operating income | -20.313 M | -17.411 M | -11.889 M | -18.712 M | -10.765 M | 4.222 M | -12.139 M | |
Ebit | -20.313 M | -17.411 M | -11.889 M | -18.712 M | -10.765 M | 4.222 M | -12.139 M | |
Pretax income | -20.321 M | -17.351 M | -11.640 M | -18.419 M | -11.338 M | 1.060 M | -1.802 M | |
-14.62% | -32.91% | 58.24% | -38.44% | -109.35% | -270.00% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -20.321 M | -17.351 M | -11.640 M | -18.419 M | -11.338 M | 1.061 M | -1.802 M | |
14.62% | 32.91% | -58.24% | 38.44% | 109.36% | -269.84% | |||
Net income | -20.321 M | -17.351 M | -11.640 M | -18.419 M | -11.338 M | 1.061 M | -1.802 M | |
14.62% | 32.91% | -58.24% | 38.44% | 109.36% | -269.84% |